Clinical Trials in Florida

Showing 8501-8520 of 12,796 trials

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

NCT00938431

The purpose of this study was to evaluate the safety and pharmacokinetics of LCM syrup in children ages from 1 month to 17 years with uncontrolled partial seizures when added to 1 to 3 other antiepileptic drugs (AEDs).

Epilepsy

UCB Pharma47 participantsStarted Nov 2009

Sacramento, California, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +18 more locations

UNKNOWNPhase 249 miles

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

NCT03205345

This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of emricasan in improving event-free survival based on a composite clinical endpoint (where all-cause mortality, new decompensation events, and MELD score progression are events) in subjects with decompensated NASH cirrhosis.

Decompensated Cirrhosis

Conatus Pharmaceuticals Inc.210 participantsStarted Jun 2017

Chandler, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +73 more locations

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Find Trials by Condition in Florida

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

FLO for Discogenic Pain

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Driveline Silicone Skin Interface Registry

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients

A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

Safety Study of ExAblate for the Treatment of Uterine Fibroids

Dating Matters: Strategies to Promote Healthy Teen Relationships

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

UltraShape Power for Abdominal Fat and Circumference Reduction

52-104 Week Off-therapy Second Extension to Study CSPP100A2365

Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)

An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis